| | | Single nucleotide variant (missense variant +1 more) | Myofibrillar myopathy 3 +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | not provided +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Myofibrillar myopathy 3 | |
| | | Single nucleotide variant (missense variant +1 more) | Myofibrillar myopathy 3 | |
| | | Deletion (frameshift variant +1 more) | Myofibrillar myopathy 3 | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | MYOT-related disorder +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | not provided +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (missense variant +2 more) | Myofibrillar myopathy 3 | |
| | | Single nucleotide variant (5 prime UTR variant +2 more) | Myofibrillar myopathy 3 +1 more | |
| | | Single nucleotide variant (5 prime UTR variant +2 more) | Myofibrillar myopathy 3 | |
| | | Single nucleotide variant (5 prime UTR variant +2 more) | not specified +4 more | GConflicting classifications of pathogenicity |
| | MYOT, PKD2L2-DT (A125fs +1 more) | Deletion (5 prime UTR variant +1 more) | not provided +1 more | |
| | MYOT, PKD2L2-DT (A131V +1 more) | Single nucleotide variant (5 prime UTR variant +1 more) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (A16E +1 more) | Single nucleotide variant (5 prime UTR variant +1 more) | Inborn genetic diseases +1 more | |
| | MYOT, PKD2L2-DT (A137T +1 more) | Single nucleotide variant (5 prime UTR variant +1 more) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (I142V +1 more) | Single nucleotide variant (5 prime UTR variant +1 more) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (T170P +1 more) | Single nucleotide variant (5 prime UTR variant +1 more) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (Q177E +1 more) | Single nucleotide variant (5 prime UTR variant +1 more) | not provided +1 more | |
| | MYOT, PKD2L2-DT (A186S +2 more) | Single nucleotide variant (missense variant) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (R188K +2 more) | Single nucleotide variant (missense variant) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (D19E +2 more) | Single nucleotide variant (missense variant) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (S210L +2 more) | Single nucleotide variant (missense variant) | not provided +1 more | |
| | MYOT, PKD2L2-DT (V112fs +2 more) | Deletion (frameshift variant) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (S45N +2 more) | Single nucleotide variant (missense variant) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (R67H +2 more) | Single nucleotide variant (missense variant) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (M144V +2 more) | Single nucleotide variant (missense variant) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (T105R +2 more) | Single nucleotide variant (missense variant) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (T333I +2 more) | Single nucleotide variant (missense variant) | Myofibrillar myopathy 3 +2 more | |
| | MYOT, PKD2L2-DT (D155N +2 more) | Single nucleotide variant (missense variant) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (E178K +2 more) | Single nucleotide variant (missense variant) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (P376S +2 more) | Single nucleotide variant (missense variant) | not provided +1 more | |
| | MYOT, PKD2L2-DT (E203K +2 more) | Single nucleotide variant (missense variant) | not provided +2 more | |
| | MYOT, PKD2L2-DT (D286E +1 more) | Single nucleotide variant (missense variant) | not provided +4 more | GConflicting classifications of pathogenicity |
| | MYOT, PKD2L2-DT (D228H +2 more) | Single nucleotide variant (missense variant) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (A429G +2 more) | Single nucleotide variant (missense variant) | Limb-Girdle Muscular Dystrophy, Dominant +5 more | GConflicting classifications of pathogenicity |
| | MYOT, PKD2L2-DT (T317S +2 more) | Single nucleotide variant (missense variant) | not specified +2 more | |
| | MYOT, PKD2L2-DT (C434R +2 more) | Single nucleotide variant (missense variant) | not provided +1 more | |
| | MYOT, PKD2L2-DT (R455Q +2 more) | Single nucleotide variant (missense variant) | Cardiomyopathy +3 more | GConflicting classifications of pathogenicity |
| | MYOT, PKD2L2-DT (N467K +2 more) | Single nucleotide variant (missense variant) | Myofibrillar myopathy 3 +4 more | |
| | MYOT, PKD2L2-DT (L471F +2 more) | Single nucleotide variant (missense variant) | Myofibrillar myopathy 3 +1 more | |
| | MYOT, PKD2L2-DT (V473A +2 more) | Single nucleotide variant (missense variant) | Myofibrillar myopathy 3 | |
| | MYOT, PKD2L2-DT (E296G +1 more) | Single nucleotide variant (missense variant) | not provided +2 more | GConflicting classifications of pathogenicity |